Skip to content

← All stories

Markets

Baird raises Climb Bio stock price target to $25 on trial data

1 source ·2 articles ·1h ago Climb Bio

Covered by 1 outlet

All coverage · 2 articles

Investing.com Canada ·1h ago

BTIG raises Climb Bio stock price target to $32 on phase 1 data

Investing.com UK ·2h ago

Baird raises Climb Bio stock price target to $25 on trial data